S
Saxon D Smith
Researcher at University of Sydney
Publications - 101
Citations - 1257
Saxon D Smith is an academic researcher from University of Sydney. The author has contributed to research in topics: Medicine & Hidradenitis suppurativa. The author has an hindex of 19, co-authored 88 publications receiving 882 citations. Previous affiliations of Saxon D Smith include Kolling Institute of Medical Research & Sydney Adventist Hospital.
Papers
More filters
Journal ArticleDOI
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Amit Garg,Erica Neuren,Denny Cha,Joslyn S. Kirby,John R. Ingram,Gregor B.E. Jemec,Solveig Esmann,L. Thorlacius,B. Villumsen,Véronique Del Marmol,Aude Nassif,Maïa Delage,Thrasyvoulos Tzellos,Dagfinn Moseng,Øystein Grimstad,Haley B. Naik,Robert G. Micheletti,S. Guilbault,Angie Parks Miller,Iltefat H. Hamzavi,Hessel H. van der Zee,Errol P. Prens,Naomi Kappe,Christine B. Ardon,Brian Kirby,R. Hughes,Christos C. Zouboulis,Georgios Nikolakis,Falk G. Bechara,Lukasz Matusiak,Jacek C Szepietowski,Amelia Głowaczewska,Saxon D Smith,Noah Goldfarb,Steven Daveluy,Christina Avgoustou,Evangelos J. Giamarellos-Bourboulis,Steven R. Cohen,Yssra Soliman,Elena Gonzalez Brant,Oleg E. Akilov,Christopher Sayed,Jerry Tan,Afsaneh Alavi,Michelle A. Lowes,José C. Pascual,Hassan Riad,Shani Fisher,Arnon D. Cohen,So Yeon Paek,Barry I. Resnik,Qiang Ju,Lanqi Wang,Andrew Strunk +53 more
TL;DR: HS patients have identified several critical unmet needs that will require stakeholder collaboration to meaningfully address in multidisciplinary care, treatment, research, advocacy, and philanthropy.
Journal ArticleDOI
Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups.
TL;DR: Anxieties associated with corticosteroid treatment and preference for ‘safer natural therapy’ are common in parents of children with atopic dermatitis and the source of these attitudes is explored.
Journal ArticleDOI
Childhood Onset Vulvar Lichen Sclerosus Does Not Resolve at Puberty: A Prospective Case Series
TL;DR: The concept that prepubertal lichen sclerosus resolves at puberty would appear not to be true in the majority of patients, as nine patients, or 75% of the cohort, who still had active licensing at puberty continue to require maintenance therapy after menarche.
Journal ArticleDOI
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
Emma Mooney,Marius Rademaker,Rebecca Dailey,Ben S Daniel,Catherine Drummond,Catherine Drummond,Gayle Fischer,Gayle Fischer,Rachael S Foster,Claire Grills,Anne R Halbert,Sarah E. Hill,Emma King,Elizabeth Leins,Vanessa A. Morgan,Vanessa A. Morgan,Roderic J Phillips,Roderic J Phillips,John Relic,Michelle Rodrigues,Michelle Rodrigues,Laura Scardamaglia,Saxon D Smith,Saxon D Smith,John C Su,Orli Wargon,David Orchard +26 more
TL;DR: Contrary to popular perceptions, (TCS) use in paediatric eczema does not cause atrophy, hypopigmentation, hypertrichosis, osteoporosis, purpura or telangiectasia when used appropriately as per guidelines.
Journal ArticleDOI
Smartphone use in dermatology for clinical photography and consultation: Current practice and the law
TL;DR: An understanding of how and why smartphones are currently used in clinical practice is critical in order to evaluate professional and legal risks, and to formulate policies that enable safe use of mobile technologies for the maximal benefit of practitioners and patients.